Compositions Anti-HTLV III Read more about Compositions Anti-HTLV III RomaniaC-20143Filed on 1986-08-08
USE OF 2',3'-DIDEOXYGUANOSINE FOR THE TREATMENT OF AIDS Read more about USE OF 2',3'-DIDEOXYGUANOSINE FOR THE TREATMENT OF AIDS Ireland1994/0570Filed on 1986-08-26
INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'-... Read more about INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'-... Hong Kong94000270Filed on 1986-08-08
Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxyinosine, 2'3'-dideoxyguanosine, or 2'3'-dideoxyadenosine Read more about Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxyinosine, 2'3'-dideoxyguanosine, or 2'3'-dideoxyadenosine European Patent86306494.5Filed on 1986-08-21
INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3' - DIDEOXYINOSINE Read more about INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3' - DIDEOXYINOSINE Cyprus86306494.5Filed on 1986-08-21
Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof Read more about Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof Japan2001-562705Filed on 2001-02-23
Anti-EGFRvIII SCFVs With Improved Cytotoxicity and Yield Immunotoxins Based Thereon, and Methods of Use Thereof Read more about Anti-EGFRvIII SCFVs With Improved Cytotoxicity and Yield Immunotoxins Based Thereon, and Methods of Use Thereof European Patent01914471.6Filed on 2001-02-23
NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 Read more about NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 Canada2398743Filed on 2001-01-26
NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 Read more about NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 Australia2001033062Filed on 2001-01-26
Determination of Adrenomedullin-Binding Proteins Read more about Determination of Adrenomedullin-Binding Proteins European Patent00961705.1Filed on 2000-09-08